Ulinastatin, a protease inhibitor, attenuates intestinal ischemia/reperfusion injury.
Li
X K
XK
First Department of Surgery, Hamamatsu University School of Medicine, Japan.
Suzuki
H
H
Kimura
T
T
Kawabe
A
A
Uno
T
T
Harada
Y
Y
D000818:Animals; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D006023:Glycoproteins / Q000494:pharmacology*; D007413:Intestinal Mucosa / Q000473:pathology / Q000503:physiopathology*; D007511:Ischemia / Q000473:pathology / Q000503:physiopathology*; D007583:Jejunum / Q000098:blood supply* / Q000473:pathology; D008297:Male; D009130:Muscle, Smooth / Q000098:blood supply; D009504:Neutrophils / Q000201:enzymology; D009195:Peroxidase / Q000032:analysis / Q000097:blood; D051381:Rats; D017207:Rats, Sprague-Dawley; D012016:Reference Values; D015424:Reperfusion; D015427:Reperfusion Injury / Q000517:prevention & control*; D014361:Trypsin Inhibitors / Q000494:pharmacology*
D015415:Biomarkers; D006023:Glycoproteins; D014361:Trypsin Inhibitors; D009195:Peroxidase; C028665:urinastatin